Soleno Therapeutics (SLNO) Net Income towards Common Stockholders Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,228.66% |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 171.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 171.68% |
| Dec 31, 2025 | 177.77% |
| Sep 30, 2025 | 133.95% |
| Jun 30, 2025 | 78.46% |
| Mar 31, 2025 | -104.57% |
| Dec 31, 2024 | -373.83% |
| Sep 30, 2024 | -650.55% |
| Jun 30, 2024 | -157.83% |
| Mar 31, 2024 | -156.08% |
| Dec 31, 2023 | -109.73% |
| Sep 30, 2023 | -63.72% |
| Jun 30, 2023 | -25.03% |
| Mar 31, 2023 | -44.74% |
| Dec 31, 2022 | -86.94% |
| Sep 30, 2022 | 24.75% |
| Jun 30, 2022 | 38.85% |
| Mar 31, 2022 | 36.95% |
| Dec 31, 2021 | 62.28% |
| Sep 30, 2021 | -5.46% |
| Jun 30, 2021 | 0.96% |
| Mar 31, 2021 | 1.36% |
| Dec 31, 2018 | 95.93% |
| Sep 30, 2018 | 67.00% |
| Jun 30, 2018 | 53.67% |
| Mar 31, 2018 | 38.95% |
| Dec 31, 2017 | -22.10% |
| Sep 30, 2017 | 79.78% |
| Jun 30, 2017 | 20.33% |
| Mar 31, 2017 | 80.25% |
| Dec 31, 2016 | 8.13% |
| Sep 30, 2016 | -94.38% |
| Jun 30, 2016 | 62.35% |
| Mar 31, 2016 | -75.65% |
| Dec 31, 2015 | 31.72% |
| Sep 30, 2015 | -58.70% |
| Jun 30, 2015 | -53.97% |
| Mar 31, 2015 | -126.40% |
| Dec 31, 2014 | -379.25% |
| Sep 30, 2014 | -32.67% |